The Latest Breaking News from UHS

Universal Health Services is scheduled to announce its fourth-quarter results next month, with analysts anticipating a double-digit earnings growth.

Despite Universal Health’s recent underperformance relative to Nasdaq, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Although Universal Health has outperformed relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook about the stock’s prospects.

Universal Health Services will release its third-quarter earnings this month, and analysts anticipate a double-digit bottom-line growth.

Universal Health (UHS) reported robust financial results in the last quarter and raised its full-year outlook. The company's widespread operations, reputation, and high profitability continue to drive growth. So, let’s analyze whether it is the right time to buy, sell or hold UHS before its earnings. Read more to find…

Universal Health Services has substantially outperformed the S&P 500 over the past year and analysts remain moderately bullish about the stock’s prospects.

Summary Universal Health Services (UHS) shows strong technical indicators with 88% buy signals, 79.75% gain in the last year, and a Trend Seeker buy signal. UHS operates acute care hospitals and behavioral health facilities, with a market cap of $15.34 billion and a P/E ratio of 16.74. Analysts offer mixed...

Despite Universal Health Services’ outperformance relative to the broader market over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

The youngster was diagnosed with pelviureteric junction obstruction

Universal Health Services is all set to announce its second-quarter results this month, and Wall Street analysts predict a solid double-digit earnings growth.

Known as gastro-oesophageal reflux disease, the condition occurs when contents from the stomach flow back into the oesophagus the stomach.